G-quadruplex, a unique secondary structure in nucleic acids found throughout human genome elicited widespread interest in the field of therapeutic research. Being present in key regulatory regions of oncogenes, G-quadruplex structure regulates transcription, translation, splicing, telomere stability etc. Changes in its structure and stability lead to differential expression of oncogenes causing cancer. Thus, targeting G-Quadruplex structures with small molecules/ other biologics has shown elevated research interest. Covering previous reports, in this review we try to enlighten the facts on the structural diversity in G-quadruplex ligands aiming to provide newer insights to design first-in-class drugs for the next generation cancer treatment.
Thirty years ago, Aaron Klug made a statement about the in vivo existence of G-quadruplex scaffolds: "If G-quadruplexes form so readily in vitro, nature will have found a way of using them in vivo". Bioinformatics analysis has predicted that human genome has ~700,000 putative G-quadruplex forming sequences (PGQS) 7 . The interesting fact is these structures are not at all randomly located rather they are significantly associated with some key regulatory areas like telomere, replication origin, promoter, 5'-UTR and 3'-UTR, Ribosome binding sites (RBS) and in long non-coding RNA where they modulate gene expression suggesting that G4 structures may play a pivotal role in the control of a variety of cellular processes. Quadruplex located in promoter generally have an inhibitory effect to the gene expression, whereas those in 5'-UTR and 3'-UTR generally modulates translation 8 , miRNA binding 9 , pre-mRNA splicing 10 , alternate polyadenylation 11 and mRNA targeting 8 . Strikingly, these structures are often present in proto-oncogenes and apparently absent in tumour suppressor genes, which suggests evolutionary selection for G-quadruplex structures based on their function 12, 13 .
These PGQS were first identified within human telomeric DNA. The structure and stability of telomeres are closely related to cancer 14 , aging 15 , and genetic stability. G4 in telomeres acts as tumor suppressor by inhibiting telomerase thereby maintaining the telomere [16] [17] [18] . Telomeric quadruplexes are highly conserved and are associated with numerous telomeric proteins 19 .
Studies led by Picard et al found that almost 80% of replication origins overlaps with a PGQS 20 . G4 structures are also formed during replication acting as 'roadblocks' and impede replication fork progression 21 ( Figure 2 ). Evidence came from the loss-of-function mutation of DOG1 gene (FNACJ helicase) known to resolve quadruplex structures ensuing in hoarding of ~50-300 nucleotide upstream of potential G-quadruplex motifs 22 . Certain G4 structures also play a positive role in replication initiation. Research by Valton et al pointed to the fact that deletion of G4 motifs in med14 origin led to the dramatic decrease in replication origin activity 23 also point mutation in consensus G4 motif β A led to much lower replication origin activity compared to wild type cell 23 .
In-silico studies exposed the fact that G4 motifs are mostly clustered in promoter regions of almost 20,000 genes 24 . Several oncogenes like c-MYC 25 , BCL2 26 , c-KIT 27 , K-RAS 28 , VEGF 29 , RB 30 , PDGF-A 31 , hTERT 32 , etc harbours a putative stable G4 structure 1 kb of each side of Transcription start site (TSS) 33 . In most of these cases the PGQS acts as a transcription repressor thereby maintaining a threshold level of transcript of the gene ( Figure 2 ).
Studies have shown that stabilization of G4 structure in NHEIII1 results in decreased expression of the c-MYC transcription. Similarly, the guanine rich strand on the proximal promoter region of the VEGF gene regulates its expression. Stabilization of this G4, downregulates the VEGF expression 34 . Ribosome biogenesis, occurring in nucleolus, is meticulously controlled by multiple cell signalling pathways and the quadruplex in non-template strand 35 . Synthesis of rRNA is the rate limiting step of ribosome biogenesis. There are two G4 -NUC 19P and NUC 23P -present in the ribosomal DNA (rDNA) 36 , which controls the rate of synthesis of rRNA.
Formation and stabilization of these quadruplex by nucleolin protein results in overexpression of rRNA 37 . Here quadruplex acts as a transcriptional activator.
There are several other examples which corroborates to the fact that G-quadruplexes are key regulatory checkpoints inside the cell. Genome-wide-survey of G4 motifs across several species has concluded that they are evolutionary conserved ratifying their important functional role in biology 12, 38 .
After the evidence of the in-vivo existence of G-quadruplexes was established using specific antibodies against parallel and antiparallel G-quadruplexes formed in telomeric DNA of the ciliate Stylonychia lemnae 39 , directive and quantitative visualization of DNA G-quadruplex structures in mammalian cells was recently reported 40 . With structure-specific antibody BG4, the G-quadruplex was visualized forming in telomeres and outside of telomeres and formed in a replication-dependent manner in the cell cycle. More importantly, the increased BG4 foci number was observed after treatment with the G-quadruplex binding ligand, indicating that the small molecule could trap and stabilize a G-quadruplex in human cells 40 . In addition, the practical high-throughput DNA sequencing showed the significant co-localization of G4s with antibody 1H6 41 , BG4 40 , hf2 42 , γH2AX 43 and DEAH/RHA family of helicases 44 . All these substantial evidences not only provide for the existence and location of G4s in the genome but also implicate the profound function of G-quadruplexes. A specific small molecule could modulate these structures in cells, which strongly supports the therapeutic potential of targeting a G-quadruplex.
Modes of G-quadruplex-Ligand Interaction
From the example shown above it is clear that presence of G-quadruplex in and around key oncogenes makes it a suitable site for drug targeting. There are many ligands which binds to G-quadruplex either to stabilize or destabilize it. G-Quadruplexes have several interaction sites.
Since true intercalation (opening of the two quartet to incorporate a planar molecule) is not possible, end stacking is more preferred mode of binding, as it does not require the transient unstacking of G-quartet 45 . Several ligands rather than binding to pre-formed quadruplex facilitates the guanine rich region to fold to quadruplex. Kinetic study has led to the better understanding of the mechanism of these events. A perylene derivative called PIPER ( Figure   5 ) is an example of such compound which promotes the folding of telomeric sequence TTAGGG to dimeric and tetrameric G4s 46 . Generally, most of the ligands possess similar chemical structure namely planar aromatic ring and charged side chain. The G-quadruplex forms an ideal platform where ligand can bind with π-π stacking. Some exploit the groove formed by the backbones and bind to the G4, which mainly include the terminal G-tetrads, the middle G-tetrads, the grooves/loops/backbones, and the central channel. Ligands with planar aromatic rings interact with the G-quadruplexes mainly through π-π stacking on the terminal G-tetrads and less through intercalating into the G-tetrads [47] [48] [49] . Ligands containing amino groups and (or) side chains can interact with the grooves, loops, and the negatively charged phosphate backbone of the G4s 50, 51 . The amino groups become positively charged by protonation or methylation, which may result in better recognition and stronger binding to the grooves as well as to the negatively charged phosphate backbone through electrostatic interactions 52, 53 . The side chains can recognize the loop bases and grooves by forming hydrogen bonds, which also improves the water solubility of the ligands. More interesting is that small-sized ligands with long positively charged side chains can lie at the central channel of a G-quadruplex, which in turn leads to an increase in the stabilization of the G-quadruplex.
Research has indicated that although planar ligands can insert into the G-tetrad layers, charged molecules are more inclined to interact with the grooves, loops or backbones of G -quadruplex structures 53, 54 .
Diversity of G-quadruplex interactive ligands (A) Oncogene specific ligand
Now a days supressing the expression of an oncogene or developing an inhibitor for a particular protein is an effective way to treat cancer. But it is not full proof method as the inhibitors is not that selective and it binds to other proteins having sequence similarity. At this juncture quadruplex comes to rescue as they are a perfect target for drug/ligands as certain vital oncogenes harbour a quadruplex in them which regulates their expression. Thus, developing molecule with high drug-likeness and G4 specificity is the key to generate next-gen anti-cancer drug. In this section we discuss some crucial oncogenes that are found to be most over-expressed across all types of tumor and cancer and ligands that are specific to those oncogenic quadruplexes.
Telomere
Telomere protects the chromosome end from shortening and regulates senescence and apoptosis 55 . Telomerase, a telomeric G4 binding protein, plays a key role in tumorigenesis 56 .
This, together with the fact that telomerase is over-expressed in >85% of all tumors and across all tumor types, suggest that embarrassment of telomerase would be an operative anticancer therapeutic tactic 57 . Since telomerase binds to telomeric G4, the later becomes a fine druggable target for cancer treatment. The most well studied ligand that was first developed against telomere G4 to inhibit telomerase was the N,N'-(9-((4- (Figure 2 ) in short. The specification of B19 to G4 is due to an acridine core and a nitrogen atom in the heterocyclic frame that could be protonated at physiological environments 50 . As a result, the electron deficiency in the chromophore was amplified, with subsequent boost of the G4 interaction 58 . These classes of compounds muddle to G4 via π-π interaction and additionally requests tertiary amine groups, since it is protonated at physiological pH, in their side chain to interact with the grooves 59 . Telomestatin is another naturally occurring compound that binds most tightly to the telomeric G4. Though it has an EC50 value of 5 nM, research by Anne De Cian and colleagues show that it might not be that potent as it was claimed 60 .
hTERT
As mentioned earlier, the transcriptional instigation of this telomerase reverse transcriptase (hTERT) gene is crucial during tumorigenesis, its expression remains repressed in adult somatic cells 61 . Thus, the expression of hTERT gene is highly regulated by several transcription factors as well as epigenetic state. It also harbors a G4 structure in its core promoter which regulates the expression of the catalytic subunit of the telomerase 62 . Mutations in the hTERT promoter has been reported in >75% of glioblastomas, melanomas 63, 64 and in aggressive thyroid cancer 65 and most importantly all these mutations are found to be in the G-rich region which forms quadruplex 32 . Metastasis suppressor non-metastatic 2 (NME2) and RE1-silencing transcription factor (REST)-lysine-specific histone demethylase 1 (LSD1) co-repressor complex associates with the G4 in hTERT promoter to repress the expression of telomerase 61 . In most of the cancer the hTERT G4 gets resolved to duplex DNA and in absence of G4 structure the NME2 and REST co-repressor complex fails to bind to the promoter resulting in the high level of telomerase expression leading to cancer and tumorogenesis. So technically stabilizing the hTERT G4 in cancer cell seemed to be novel therapeutic avenue. On treating with eleven G4 specific ligands ∼50-85% downregulation of hTERT is seen in HT1080 cells (Figure 2 66 . It is also more specific to hTERT G4 than telomeric quadruplex. Compared to telomestatin and B19, 12459 was found to be more potent in achieving 50% inhibition in annealing the Guanine rich strand with its complementary strand. The IC50 value of the reaction was found to be 1.75±0.37 µM for G4TERT1 sequence, which is way less than telomestatin and B19 which had IC50 value of 5.0±1.7 and 5.7±1.1 respectively 66 . It also induces massive telomeric dysfunction along with DNA damage at 0.5-1 µM concentration 67 . Hence to conclude we can assume that 12459 induces the formation of G4 structure causing alternative splicing to reduce active telomerase formation. Stabilizing the G4 also allows the NME2 and REST co-repressor complex to bind to it and repress telomerase expression.
BCL2
Certo cells respectively 80 . Whereas AQ7, being a better c-KIT quadruplex binder, showed meagre to no cytotoxicity. This is could be due to the inability of AQ7 in reaching intracellular target due to its large side chain. This proves that affinity always does not corresponds to cytotoxicity. 
rDNA
In genome perhaps, the densest population of G4 after telomere is present in rDNA having 12% more G4 than rest of the genome 84 . There are approximately 1500 G4 motifs in rDNA nontranscribed strand that act as transcription activator 84 . RNA Polymerase I complex (Pol I) is responsible for transcription of rRNA genes and as a result control ribosome biogenesis.
Studies by Merenzini et al have found that in cancer the Pol I activity and rRNA synthesis is remarkably high 85 . Nucleolin stabilizes these G4 structure and enhances the activity of Pol I, to synthesise more rRNA 86, 87 . Thus, this nucleolin/G4 complex offers a potential therapeutic target to treat cancer. A fluoroquinolone derivative called quorfloxin ( Figure 3 ) have been developed which targets and disrupts nucleolin/G4 complex inducing apoptosis in cancer cells. 
(B) Classification based on backbone

Anthraquinone derivatives
In 1997, Neidle and Hurley group reported the first quadruplex-interactive ligands as a telomerase inhibitor molecule i.e. 2,6-Diaminoalkylamido-anthraquinone, BSU-1051 ( Figure   4 ) with a telomerase IC50 of 23µM 93 . From there on,wide range of the disubstituted amidoanthraquinone family such as 1,4-, 1,5-, 2,6-, and 2,7-isomers were developed with substituents at various positions on the chromophore and by changing side chain length and size, and the nature of the side chain terminal groups were modified by systemic structurefunction studies. Molecular modelling studies showed that anthraquinone compounds bind to G4 by a 'threading intercalation' mode with π-π overlapping , where any flexible side chains can protrude into wider grooves of G4 and same binding mode is also observed for dsDNA too. Therefore, these compounds are not that much selective and specific for quadruplex DNA and thus their cytotoxicity can be high.
To reduce the cytotoxicity , a carbonyl group was removed from the anthraquinone moiety, a series of disubstituted 2,7-amido-fluorenones(2,7-FO) were designed and synthesized by removing a carbonyl group from the anthraquinone moiety thus preventing redox cycling 94 .
These 2,7-FO derivatives has less telomerase IC50 values of 8-12 µM with upto 10 fold reduced cytotoxicity , compared with that of their parent anthraquinone derivatives in different human cancer cell lines. This slighty less telomerase activity of 2,7-FO derivatives with that of parent molecule is due to decreased electron deficiency in the chromphore and the curved scaffold which is not favourable for pi-stacking interaction with G4 structures 94 .Tetracyclic anthraquinone analogues with another heterocycle attached to the anthraquinone core in place of side chains were reported and these compounds show anti-telomerase activity, because they also interact with G-quadruplex. For benzonaphtho-furan compounds, modifications of tricyclic anthraquinones to tetracyclic derivative are also synthesized. Molecular models showed that tetracyclic compounds provide more surface area suitable for stacking interaction with G-quartet.
Acridine derivatives
Chromophore containing positively charged central ring has been extensively used for designing G4 binding ligands as the positively charged ring is likely to be complementary to the channel of G-quadruplexes with negative electrostatic potential. Thus,to overcome the problem of the specificity and selectivity of anthraquinones for quadruplex DNA and duplex DNA, Neidle and his groups modified the acridine core and its side chains by introducing a pyridine ring in the ligand core in place of quinine which increase the positive charge of the ligand core thus enhancing the electrostatic interaction with the negatively charged G-quartet channel 95 . They synthesized a series of 3,6-disubstituted acridines including BSU 6039 ( Figure   5 ) 96 . But these compounds failed to increase telomerase inhibition probably because of the insufficient basicity of the pyridine ring nitrogen. Based on X ray crystal structures and molecular modelling study of the complex between telomeric G4 and BSU 6039, disubstituted 100 . This high activity is due to the strong electrostatic interaction between the positively charged ligand core, containing methylated quaternary nitrogen and negatively charged quadruplex centre. However, this small size aromatic compound can also intercalate into duplex DNA with modest selectivity. Based on the finding that oxidized riboflavin binds to an intramolecular G-quartet with moderate affinity trisubstituted isoalloxazines were also synthesized . These compounds are not that much selective against duplex but some trisubstituted isoalloxazines were found to be approximately 15-fold more selective for quadruplex found in the c-kit promoter than that of telomeric G4 100 . This result indicates that coplanar tricyclic drug like small molecules can easily selectively bind to G4 over duplex DNA. Recent studies have shown that simple anthracenes with tethered side chains at appropriate positions can also act as selective G-quadruplex ligands.
Bis-aryl Compounds
Bis aryl compounds are one of the most extensively used G4 stabilizing ligand. These compounds contain two symmetrical aromatic ring connected to the core, thus giving a 'butterfly" like appearance. A variety of aromatic rings have been reported including, quinolinium, triazole, benzimidazole, and substituted phenyl rings. Linkers like urea, benzene, diketene, pyridine, benzene are attached to the core. Due to their flexible rotation of the linkers, they can adapt different structural conformation so that they can fit into groove and loops of G4, thus showing higher binding affinity to G4.
First reported bis-aryl compounds were bis-quinolinium triazines (compound 12459) 101 .These compounds show low cytotoxicity and acts as a potent human telomerase inhibitor ( tel IC50= 0.13µM) 102 . Later derivatives of bisquinolinium compounds with a pyridodicarboxamide (PDC) core (e.g. Compounds 360A) were synthesized and these compounds were found to be 100 times more selective to G4 than duplex DNA 103 . Internal syn-syn hydrogen bond favours these ligands to interact G4 with high selectivity. Later Phen-DC derivatives ( Figure 4) were synthesized with an expanded aromatic core,by replacing pyridine with bipyridine or phenanthroline and showing higher selectivity and specificity towards G4 than duplex DNA 104 .
Phen DC derivatives also exhibit anti-telomerase activity with tel IC50 value of 0.3µM.
Ligands with diarylurea skeleton are extensively studied due to their drug like characteristics.These ligands contains 1,2,3-triazole rings attached to a diphenyl urea moiety 105 .
These ligands can orient themselves by locating urea oxygen atom over the ion channel and allowing deep penetration of the side chains into G4 grooves by triazole-phenyl bond rotation thus stabilizing G-quartet more efficiently by π-stacking interactions. Further modelling studies suggested that the ortho-and meta-substituted analogues are optimal for G4 DNA affinity as they can adopt a "square-planar" conformation, than that of the para-substituted ligands which are sterically too large for optimal interaction with the G-quartet. Also, the formation of an intramolecular H-bond, ortho-substituted analogues are conformationally constrained by the urea NH and the triazole-N3 atom, which enforces the desired "square-planar" conformation 105 .
Due to the presence of three rotatable bonds in the scaffold, triphenylpyridine is one of the most rigid and diverse skeletons as G4 ligand. The side chains positioned by central core help to discriminate different G4 loops. Compounds with two amine chains linked directly to the aryl rings, with piperazine(N-Ppz) substituents confers specificity and the highest affinity to human telomeric and c-KIT2 G4 DNA, but they failed to discriminate between them significantly. From the data of different substitution reaction, suggests that the protonation of the amine is critical. According to FRET study , compounds with a para-thiomethylphenyl or para-bromophenyl substituent on the central pyridine ring and four carbon atom length side chains, confers the highest stability and specificity towards all G4 DNA sequences reported till date over dsDNA. Compounds containing thiophene, furan and piperonal units exhibit much higher specificity for G4 over dsDNA but with moderate stabilization and also ligands with alkyl amine phenyl ether, bulky benzyl ether and para-dimethylaminophenyl 4-substituents on the central pyridine present the poorest G4 stabilization.
Oxazole derivatives
Telomestatin (SOT-095), a macrocyclic natural product that was isolated from Streptomyces annulatus 3533-SV4 in 2001 by Shin ya et al, which consists of seven oxazole rings and one thiazoline ring and this is currently the most effective in-vitro telomerase inhibitor, with an tel IC50 value of 5 nM obtained from TRAP assay 106 . This compound selectively binds to intramolecular G4 rather than intermolecular quadruplex and specific to G4 than duplex DNA with more than 70-fold preference. Molecular dynamics study confirmed that telomestatin overlaps with four guanine residues by the help of stacking interaction onto it thus stabilizing the G4 at a greater extent. 
Porphyrin derivatives
Porphyrins are one of the most well studied binding agents for duplex DNA by intercalating interaction. The aromatic rings of porphyrin give them a planar arrangement and thus binds to the G4s too by stacking interaction with the G tetrads. Porphyrins have four N-methylated pyridines. Water solubility and π-π stacking interactions are increased by the polycationic moiety due to ionic configuration and decreased electron density of the core aromatic system.
Hurley et al reported TMPyP4 as the type molecule of this class (Figure 4). From CD melting
analysis and NMR experiments, it has been reported that TMPyP4(tetra-(N-methyl-4-pyridyl)porphyrin was found to bind both duplex DNA, parallel and antiparallel G-quadruplex structures with only two fold greater affinity for G4 than duplex DNA 109, 110, 116 . Thus, TMPyP4
showed poor selectivity for G4 over duplex DNA. Later, it was found that TMPyP4 binds and stabilizes different G4 in oncogenic promoters like K-RAS, c-MYC, BCl2 etc. CD melting and ITC experiments suggested that, TMPyP4 binds to c-MYC Pu27 G4 at a TMPyP4/Pu27 stoichiometry of 4:1. But, its isomer TMPyP2 (tetra-(N-methyl-2-pyridyl) porphyrin showed very weak affinity to G4s.From the NMR Chemical shift ,it was clearly observed that TMPyP4 binds to G4 by stacking interaction externally. Recently, from the crystal structure of TMPyP4 and human bimolecular telomeric G4 complex, it was found that TMPyP4 stacked on TTA nucleotides either at the external loop or at the 5' region of the G4 ,involving hydrogen bonding between the base pairs, which are not taking part in the G4 formation 117 . As TMPyP4 is a standardized molecular skeleton to probe G4, this porphyrin skeleton is modified to increase G quadruplex selectivity and specificity. By replacing the cationic pyridinium ring of TMPyP4 with a phenol ring which possess a quaternary ammonium moiety, TQMP ,a nonpyridinium cationic porphyrin has been synthesized showing 30-fold increase in G4 selectivity than TMPyP4 through specific groove and loop binding 118 .
Later to increase specificity , expanded porphyrin derivative, 5,10,15,20-[tetra(N-methyl-3-pyridyl)]-26,28-diselenasapphyrin chloride (Se2SAP) was synthesized and reported to bind selectively to G4 DNA with a 50-fold increase over duplex DNA 111 . Se2SAP was found to bind selectively to c-MYC G-quadruplex even in the presence of other quadruplexes and duplex DNA and convert parallel c-MYC quadruplex into mixed parallel and anti-parallel hybrid conformation 119 . Even Se2SAP can bind and stabilize bcl-2 promoter quadruplex into mixed anti-parallel and parallel hybrid structures 110 . But due to the low synthetic yields this ligand failed to draw further attention. At present, pentacationic manganese (III) porphyrin, containing four flexible cationic arms attached to the central aromatic core, is the most specific ligand that can discriminate between G4 and DNA, increasing the selectivity by 10,000 folds 120 . Other
TMPyP4 variants, such as , cationic N-confused porphyrin 80, 121 , pyridyl-substituted corrole 122 , porphyrazines 123 and phthalocyanines have been recently reported. Among them, Tetramethylpyridinium porphyrazines (TMPyPz), nonsymmetrical phthalocyanine azo derivatives , was found to show higher binding affinity (by 100 fold) to human telomeric G4 than duplex DNA by 100 fold as compared with TMPyP4 123 . Zinc complex (Zn-TMPyPz) derivatives was found to show similar affinity and selectivity 124 . Later water soluble octacationic zinc phthalocyanine (ZnPc) was also found to be an effective G-quadruplex binding ligand with anti-telomerase activity ( tel IC50 = 0.23 µM) 124 .
Quinacridine analogues
In values of 0.028 and 0.5 µm, respectively 127 . Cyclic bis-quinacridine (BOQ1), scaffold is mainly composed of two quinacridines connected by polyamine linkers, having greater quadruplex selectivity than mono-quinacridine compounds. BQQ1 binds to G4 preferentially (ΔTM =+28℃) than that of duplex DNA, due to the steric hindrance effect of the macro-cyclic scaffold which makes it more favourable groove/loop interactions. Thus BQQ1 appears as one of the most potential drug scaffold targeting G4.Recently, a novel platinum-quinacridine hybrid (PtMPQ) composed of single functional Pt moiety and mono-para-quinacridine, was reported to interact with quadruplex DNA by a dual covalent-noncovalent binding mode 128 .
Berberine derivatives
Berberine, a plant alkaloid (Figure 4 ), was first isolated from Chinese herbs and reported to have anti-microbial activity but later it was established as a G4 stabilizing agent too. In 1999, berberine was reported to have anti-telomerase activity 129 and many 13-substituted berberine derivatives are synthesized by Neidle et al. These derivatives bind to G4 with very high affinity 130 . They also found that piperidino-berberine has better stabilizing effect on Gquadruplex and increased anti-telomerase activity. Huang et al. synthesized 9-subsituted berberines having an alkyl side chain with a terminal amino group, which can efficiently interact G4 with greater binding affinity than berberine. 9-subsitituted berberines are again modified by the incorporation of one extra pyridine ring on berberine scaffold and thus, quinolino-benzo dihydroisoquindolium (QBDI) compounds (Figure 4 ) are synthesized, which have enhanced G4 interacting potential due to the increased aromaticity of the QBDI backbone.
Later, it was reported that these 9-substituted berberine and QBDI derivatives possess higher selectivity for G-quadruplex DNA in c-MYC oncogene than the others.
Quindoline derivatives
Molecular modelling study of anthraquinones and acridines derivatives revealed that a tricyclic chromophore is not specific for stacking interaction to G-quartet terminal Coronene is another polyaromatic system used as a ligand. Many coronene derivatives were also synthesized , which can stabilize G4 DNA. They also had anti-telomerase activity 141 .
Later, many naphthalene diimides substitutes were synthesized by incorporating DNA alkylating groups by flexible spacers to increase G4 selectively 142 . The hydrophobic planar core of these molecules stacks on to G4 and the additional ionic interactions with the loops are increased due to the alkylated amino side chains.
(C) Ligands conjugated with peptides, nucleotides and glycosides G4 specificity and selectivity has been increased by incorporating additional structural motifs such as peptides, nucleotides and glycosides. These conjugates helped to specifically discriminate among different conformations of G4. Among them synthetic peptide-ligand conjugates are extensively studied. Specific tetrapeptides like RKKV, KRSR, and FRHR were tethered to the side chains of acridine ligands which shows higher affinity and specificity towards G4 over duplex DNA by interacting with the quadruplex loops [143] [144] [145] .
NCQ, a neomycin (aminogylcoside) capped macrocycles was reported to bind G4 by interacting with the G-quartet and the loop by the formation of hydrogen bonds between base pairs and the amino and hydroxyl groups of neomycin 146 . Later it was found that NCQ specifically binds to loop-containing G4 than non-loop containing G4s. An open neomycinperylene conjugate has also been reported recently with both base stacking and groove binding intaerction 147 .
Acridine-oligonucleotide conjugates were also designed and found to interact with both single stranded telomeric sequences and G4 structure 148 . Several peptide nucleic acids (PNA) were also synthesized 149 . Acridone scaffold was modified by conjugating peptide containing guanine repeats and found to interact with single-stranded fragment of telomeric DNA, forming a (1+3) hybrid quadruplex 149 . Oligonucleotide conjugates interact with both external surface of G4 and its central scaffold. Thus, such ligand conjugates serve as an efficient G4 binding scaffold for better recognition, higher specificity and improved solubility. Above all, it is necessary to choose the right biomolecules for designing future ligand conjugates with higher bioavailability, biocompatibility and lower cytotoxic effects.
(D) Peptide selective to G-quadruplex:
Apart from other biologics (Protein and DNA) peptide offer an attractive therapeutic potential that could be used to target G4. Peptide mimics as a protein and interacts sturdily and selectively with its target quadruplex. Being smaller sized it is non-immunogenic, and its ease of synthesis permits it to be synthesized in industrial quantity. Peptides are also non-toxic and present combinatorial chemistry allows the development of series of peptide having wealth of therapeutic potential. Though the research with developing anti-cancer peptide that targets G4
is at a pre-mature stage, still some worthwhile work has been carried out. (Table 2) stabilizing it and probably pushes proliferating cells towards apoptosis. But since LL37 is a large protein it is cell membrane impermeable also the binding affinity of LL37 towards Gquadruplex is too weak for it to become a viable drug.
Jana et al. reported that LL37
To address these issues, our group had truncated the quadruplex binding domain of LL37 and made some selective mutations to increase the affinity towards c-MYC G4 developing a peptide molecule, KR12C (Table 2) , which is highly specific to previously undruggable c-MYC G4 and stabilize it by 9 ○ C as observed from Circular Dichroism melting experiment. We also observed binding affinity (KD) of the peptide to the c-MYC G4 is 901 nM 151 through Isothermal titration Calorimetry, in the presence of MCF-7 nuclear extract (which mimicked a molecular crowding condition). KR12C was involved in a multitude of electrostatic and weaker CH3-π interactions to impart selectivity and stability to MYC G4 structure. The guanidino group of R12 attaches to the sugar phosphate backbone of by electrostatic interaction. Similarly, the penultimate R2
at N-terminus clings to the sugar-phosphate backbone of 5' end of MYC G4 151 . These two connections were extremely steady as experimented from Molecular Dynamics Simulation.
They protected the G-quartet proximal to 5′-terminus by gripping the backbone of the guanines delineating the quartet. Furthermore, L11 and I7 came into spatial proximity of the terminal quartet and stabilized the Hoogsteen hydrogen bonding between via CH3-π interactions 151 .
This peptide also downregulates c-MYC transcription by ~5 fold 151 . The peptide achieved this feat by binding to the G4 and depleting the occupancy of both NM23-H2 and Nucleolin.
Kobayashi et al also developed a peptide library to check interaction of the peptides with various quadruplexes by electrophoresis. He generated two series of peptides with the hope to find NRAS/cMYC/WNT/FGF G4 specific peptide. He added varied amino acids to the Nterminus of the KWK motif with the hope to vary aromatic character (H, W, F, or Y), flexibility of the main chain (G or P) and charge of the peptide (K or E) 152 . It was found that peptide 003, 007 and 015 binds specifically to WNT G4 binder 152 and peptide 010 binds to c-MYC G4 152 .
They furthered their study with the peptide 010 and found that it increases TM of MYC G4 by 8 ○ C and that of FGF G4 by 4 ○ C 152 . Circular Dichroism study reported that 010 is a parallel quadruplex specific binder. Though specific studies with these peptides are yet to be done work by Kobayashi gives an excellent start point.
So, to summarize the G4 interacting peptide must have an aromatic amino acid to stack to quadruplex and must be positively charged so that it can pass through the cell membrane easily and interact with the phosphate backbone of DNA. But one major drawback of peptide is that they are susceptible to peptidases/proteases in body 153 . But it can be evaded by using several mechanisms like blocking the C-and N-termini, using D-amino acids, and chemical modifications improving their pharmacodynamic and pharmacokinetic profiles 153, 154 .
Conclusion:
Playing a major role in regulating gene expression, G-quadruplex has become a striking anticancer target. As quadruplex offer a varied biological function, targeting them has become an attractive area of drug discovery research. A fresh perspective to these motifs has led to the development of ligands that interact with these structures. In this review, we have seen that there are several small molecules developed against G4 structures. But with exception to quarfloxin none has made it till clinical trial. In-fact most of the small molecules fails to distinguish between different quadruplexes and show selectivity to more than one G4. Since G-Quadruplex have high polymorphic and flexible conformation it is difficult to design ligand that can detect and interact with these structures. The major drawback of small molecule as a quadruplex targeting drug is its off-target effect and toxicity. Sometimes these molecules degrade to produce toxic metabolite and show low body clearance. All these drawbacks must be addressed to develop a molecule as a drug. To be a G4 targeting drug any molecule must follow the following condition-(1). It must distinguish quadruplex from duplex and bind to it.
(2). It must discriminate between different G-Quadruplexes. (3) . It should have low off-target effect. (4) . It must be cell-penetrable and (5). It must not degrade to toxic metabolite in cell.
Still a molecule which checks all these criteria is yet to be discovered. Despite the presence of several therapeutic drug against cancer, multi drug resistance nature of cancer played a doom over conventional treatment. Therefore, drug discovery calls for an alternative treatment and this is why conjugative molecules and peptide as a drug is flourishing. Slowly researchers are focusing more to derive G4 stabilizing peptide. Present combinatorial chemistry and phage display library technique allows one to evaluate multiple peptide against a target and select best from the lot 155, 156 in one go. Since peptide can fold back and forth on their own, they are able to modify themselves according to changing G4 landscape while binding to them providing more selectivity and tight binding.
The ill-fated drawbacks that make G4 an elusive target can be handled by incorporating bioinformatics and computational approach which can lead to the discovery and development of more novel ligand that can distinguish varied topology of G4 with much more stringency 157 .
Adopting structure-based drug design and ligand screening from a virtual database 158 is a next step to ensure that one gets a ligand that is selective to a quadruplex. NMR and X-ray crystal structure of G-Quadruplex-ligand complex has shed light onto the atomic interactions that take place between them and this information can be harnessed to develop more potent drug 159, 160 .
Though there is still no G4 targeting ligand which can be used as a drug, G4 directed therapy is at a rise given its importance in cancer and other disease. Current research and generation of new techniques is mining out wealth of knowledge about the G4 structures and it is not long till we find next-generation G4 targeting ligands with higher therapeutics and lower cytotoxicity. 
